04 Oct, EOD - Indian

SENSEX 81688.45 (-0.98)

Nifty 50 25014.6 (-0.93)

Nifty Bank 51462.05 (-0.74)

Nifty IT 41912.5 (0.36)

Nifty Midcap 100 58474.45 (-0.93)

Nifty Next 50 74620.25 (-1.10)

Nifty Pharma 23094.7 (-0.36)

Nifty Smallcap 100 18758.65 (-1.02)

04 Oct, EOD - Global

NIKKEI 225 38635.62 (0.22)

HANG SENG 22736.87 (2.82)

S&P 5807.5 (0.80)

Login/Signup
LOGIN HERE
Cancel

Abbott India Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500488 | NSE Symbol : ABBOTINDIA | ISIN : INE358A01014 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
30-Jul-2024 07-Aug-2024 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the first quarter ended on June 30 2024. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and further to our intimation dated June 26 2024 the Trading Window of the Company remains closed from Monday July 1 2024 to Friday August 9 2024 (both days inclusive). Unaudited Financial Results of the Company for the first quarter ended on June 30, 2024 (As per BSE Announcement Dated on 07/08/2024)
29-Apr-2024 09-May-2024 Accounts ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2024 and to recommend final dividend for the year ended March 31, 2024. Outcome of Board Meeting Financial Results for the quarter and financial year ended March 31, 2024. Board approves Final Dividend (As Per BSE Announcement Dated on 09.05.2024)
13-Mar-2024 13-Mar-2024 Change in Directors The Board at its Meeting held today i.e., March 13, 2024 approved the appointment of Ms Swati Dalal (DIN: 01513751) as an Additional Director and the Managing Director of the Company with effect from April 1, 2024. Appointment of Internal Auditors for the financial year 2024-25 Abbott India Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.
18-Jan-2024 01-Feb-2024 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31 2023. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the Trading Window of the Company remains closed from Monday January 1 2024 to Saturday February 3 2024 (both days inclusive). Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2023 Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a text of Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2023, approved by the Board of Directors at its Meeting held today i.e., Thursday, February 1, 2024 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 4.00 pm and concluded at 5.35 pm. (As Per BSE Announcement Dated on 01/02/2024)
31-Oct-2023 09-Nov-2023 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the second quarter and half year ended on September 30 2023. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the Trading Window of the Company remains closed from Sunday October 1 2023 to Saturday November 11 2023 (both days inclusive). Pursuant to Regulation 47 of the SEBI (LODR) Regulations, 2015, please find enclosed the newspaper cuttings of the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2023 published in Business Standard (All Editions) and Loksatta today i.e., Friday, November 10, 2023. Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2023 (As per BSE Announcement Dated on 09/11/2023) Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2023, approved by the Board of Directors at its Meeting held today i.e., Thursday, November 9, 2023 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 11.00 am and concluded at 1.30 pm. (As Per BSE Announcement Dated on 10.11.2023)
28-Jul-2023 09-Aug-2023 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve the text of Unaudited Financial Results of the Company for the first quarter ended on June 30 2023. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations 2019 the Trading Window of the Company remains closed from Friday June 30 2023 to Friday August 11 2023 (both days inclusive). Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2023, approved by the Board of Directors at its Meeting held on today i.e., Wednesday, August 9, 2023 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 3.30 pm and concluded at 6.45 pm. Unaudited Financial Results of the Company for the first quarter ended June 30, 2023. Appointment of Company Secretary (As per BSE Announcement Dated on 09/08/2023)
08-May-2023 19-May-2023 Accounts ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 inter alia to consider and approve the text of Audited Financial Results of the Company for the quarter and year ended March 31 2023 along with the Audit Report of the Statutory Auditors thereon as required under Regulation 33 of the said Regulations to consider and approve the Audited Financial Statements for the year ended March 31 2023 and to recommend dividend. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations 2019 the Trading Window of the Company remains closed from Friday March 31 2023 to Sunday May 21 2023 (both days inclusive). Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its Meeting held today i.e., May 19, 2023, recommended payment of final dividend of Rs. 180/- and special dividend of Rs. 145/- per equity share of Rs 10/- each for the year ended March 31, 2023, subject to approval of the Shareholders at the ensuing Seventy-ninth Annual General Meeting of the Company scheduled to be held on August 9, 2023. The aforesaid final and special dividends, if approved by the Members, will be paid on and after Wednesday, August 16, 2023 onwards. Outcome of the Board Meeting held today i.e., May 19, 2023 is attached Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the Audited Financial Results of the Company for the quarter and year ended on March 31, 2023 along with Statement of Assets and Liabilities as on that date and Statement of Cash Flow, as approved by the Board of Directors at its Meeting held today i.e. May 19, 2023, along with the Auditor's Report issued by S R B C & CO LLP, Statutory Auditors of the Company. Further, pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we confirm that S R B C & CO LLP, Statutory Auditors have issued the Audit Report with unmodified opinion for the year ended March 31, 2023. A declaration to that effect from the Company is enclosed. The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 3.50 pm. In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and further to our letter dated March 17, 2023, we hereby inform you that upon recommendation of the Nomination and Remuneration and Audit Committees, the Board of Directors at its Meeting held today i.e. May 19, 2023 approved the appointment of Mr Sridhar Kadangode as Chief Financial Officer and Key Managerial Personnel of the Company effective July 1, 2023. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and Exchange Circular List/Comp/14/2018-19 dated June 20, 2018, are enclosed herewith as Annexure A. You are requested to take the same on record. (As Per BSE Announcement Dated on 19.05.2023)
17-Mar-2023 17-Mar-2023 Change in Other Executives In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the SEBI LODR Regulations'), the Board of Directors at its meeting held today i.e. March 17, 2023 have taken on record retirement of Mr Rajiv Sonalker (DIN: 07900178) as Chief Financial Officer and Whole-time Director of the Company effective close of business hours on June 30, 2023, consequent to his retirement from the employment of the Company. Mr Rajiv Sonalker will also cease to be a Key Managerial Personnel under the provisions of Section 203 and all other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI LODR Regulations for determining the materiality of any event or transaction and for making the required disclosures to the Stock Exchange effective close of business hours on June 30, 2023. This is for your information and records.
31-Jan-2023 10-Feb-2023 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve the text of Unaudited Financial Results of the Company for the third quarter ended on December 31 2022. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a text of Unaudited Financial Results of the Company for the third quarter ended on December 31, 2022, approved by the Board of Directors at its Meeting held today i.e., Friday, February 10, 2023 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 12.00 Noon and concluded at 1:50 pm. Kindly acknowledge the receipt of the same. (As per BSE Announcement Dated on 10/02/2023)
03-Nov-2022 14-Nov-2022 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve the text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30 2022. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2022, approved by the Board of Directors at its Meeting held today i.e., Monday, November 14, 2022 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 1.00 pm. (As Per BSE Announcement Dated on 14.11.2022)
29-Jul-2022 10-Aug-2022 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the first quarter ended on June 30 2022. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations 2019 the Trading Window of the Company remains closed from Thursday June 30 2022 to Friday August 12 2022 (both days inclusive). This is for your information and records. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2022, approved by the Board of Directors at its Meeting held on Wednesday, August 10, 2022 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 4.00 pm and concluded at 5.30 pm. Kindly acknowledge the receipt of the same. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations'), we hereby inform you that, upon recommendation of the Nomination and Remuneration Committee, the Board of Directors at its Meeting held today i.e. August 10, 2022, approved the re-appointment of Ms Shalini Kamath (DIN: 06993314) as an Independent Director for a term of 5 (five) years with effect from October 29, 2022, subject to the approval of the Shareholders of the Company. Additional details required pursuant to the Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, is enclosed as Annexure A. This is for your information and records. (As Per BSE Announcement dated on 10.08.2022)
06-May-2022 17-May-2022 Accounts ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2022 inter alia to consider and approve the text of Audited Financial Results of the Company for the quarter and year ended March 31 2022 along with the Audit Report of the Statutory Auditors thereon to consider and approve the Audited Financial Statements for the year ended March 31 2022 and to recommend dividend. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations 2019 the Trading Window of the Company remains closed from Thursday March 31 2022 to Thursday May 19 2022 (both days inclusive). Thank You. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its Meeting held today i.e. May 17, 2022, recommended payment of final dividend of Rs. 145/- and special dividend of Rs. 130/- per equity share of Rs 10/- each for the year ended March 31, 2022, subject to approval of the Shareholders at the ensuing Annual General Meeting scheduled to be held on August 10, 2022. The aforesaid final dividend, if approved by the Members, will be paid on and after August 17, 2022 onwards. This is for your information and records. (As Per BSE Announcement Dated on 17.05.2022)
31-Jan-2022 09-Feb-2022 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 inter alia to consider and approve the text of Unaudited Financial Results of the Company for the third quarter ended on December 31 2021. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations 2019 the Trading Window of the Company remains closed from Friday December 31 2021 to Friday February 11 2022 (both days inclusive). Kindly acknowledge the receipt of the same. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2021, approved by the Board of Directors at its Meeting held today i.e., Wednesday, February 9, 2022 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 1.50 pm. Kindly acknowledge the receipt of the same. (As per BSE Announcement Dated on 09/02/2022)
02-Nov-2021 12-Nov-2021 Quarterly Results Quarterly Results
28-Jul-2021 06-Aug-2021 Quarterly Results ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2021. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window of the Company remains closed from Wednesday, June 30, 2021 to Sunday, August 8, 2021 (both days inclusive). This is for your information and records. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2021, approved by the Board of Directors at its Meeting held on Friday, August 6, 2021 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. The Meeting of the Board of Directors of the Company commenced at 10.45 am and concluded at 11.45 am. Kindly acknowledge the receipt of the same. (As Per BSE Announcement Dated on 06.08.2021)
1 2